Fed. Circ. Won't Disturb Block On Sandoz Combigan Generic
The Federal Circuit on Thursday shot down Sandoz Inc.'s bid to modify an injunction on its generic version of Allergan Inc.'s eyedrop product Combigan, even though the generics producer had amended...To view the full article, register now.
Already a subscriber? Click here to view full article